title: Phase characterization of indomethacin in binary solid dispersions with PVP VA64 or Myrj 52.
abstract: In the present study the properties of binary solid dispersions made up of PVP VA64, Myrj 52 and indomethacin (IMC) are studied and characterized. The solid dispersions were prepared by dissolving the materials in dichloromethane, followed by solvent evaporation under reduced pressure at 55 degrees C in a rotavapor. Binary solid dispersions were characterized by standard and modulated temperature differential scanning calorimetry (MTDSC), thermogravimetry (TGA) and X-ray powder diffraction (XRPD). XRPD analysis showed that the initial IMC was in its gamma-form, and that it was transformed to the beta-form (reported to be a solvate) together with an amorphous fraction in the solid dispersions. A mixture of the beta-form and amorphous IMC was also obtained in the binary systems containing less than 30% polymer. IMC without adding polymer was subjected to the same experimental procedures as in the solid dispersions, and used as a model to characterize the solid-state transformations. The following order of transitions was observed: from the initial gamma-form, the beta-form was obtained together with an amorphous component, then the crystalline beta-form transforms into the alpha-form which melts and recrystallizes into the most stable gamma-form.
authors.affiliation: Laboratorium voor Farmacotechnologie en Biofarmacie, Faculteit Farmaceutische Wetenschappen, Katholieke Universiteit Leuven, Campus Gasthuisberg O&N2 bus 921, B-3000 Leuven, Belgium.
authors.forename: Xin
authors.initials: X
authors.lastname: Wang
authors.forename: Hector Novoa
authors.initials: HN
authors.lastname: de Armas
authors.forename: Norbert
authors.initials: N
authors.lastname: Blaton
authors.forename: Armand
authors.initials: A
authors.lastname: Michoel
authors.forename: Guy
authors.initials: G
authors.lastname: Van den Mooter
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000737:chemistry*; D002152:Calorimetry, Differential Scanning; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D005079:Excipients; D007213:Indomethacin / Q000008:administration & dosage / Q000737:chemistry*; D007536:Isomerism; D011092:Polyethylene Glycols / Q000737:chemistry*; D011759:Pyrrolidines / Q000737:chemistry*; D013501:Surface-Active Agents / Q000737:chemistry; D014753:Vinyl Compounds / Q000737:chemistry*; D014961:X-Ray Diffraction
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D005079:Excipients; D011759:Pyrrolidines; D013501:Surface-Active Agents; D014753:Vinyl Compounds; C402301:poly(vinylpyrrolidone-co-vinyl-acetate); D011092:Polyethylene Glycols; C009314:polyethylene glycol monostearate; D007213:Indomethacin